News & Press Releases

Uroviu Corporation, a leading player in single-use cystoscopy technology, has announced a significant change in its leadership. In a press release issued today, the company proudly introduced Ali Amiri as its new President and Chief Executive Officer. This appointment marks a strategic move by Uroviu to bring in a seasoned executive with a proven track record in the healthcare industry. Ali Amiri comes to Uroviu with a wealth of experience, having held key leadership positions at several prominent healthcare organizations. His expertise in navigating the complexities of the healthcare sector, combined with his innovative vision, positions him well to lead Uroviu into an exciting new chapter. The company’s decision to appoint Amiri as its President and Chief reflects its commitment to innovation and growth, as it continues to provide cutting-edge solutions that enhance the delivery of healthcare services. With Ali Amiri at the helm, Uroviu Corporation is poised for even

Asieris Pharmaceuticals, a global biopharmaceutical company dedicated to pioneering innovative treatments for genitourinary tumors and related diseases, has recently announced an exciting development in its partnership with UroViu Corporation (“UroViu”). This strategic collaboration grants Asieris exclusive global rights to utilize UroViu’s patented portable single-use cystoscope technology in the domain of fluorescent imaging. This advancement marks a significant step forward in the quest to enhance the diagnosis and postoperative monitoring of Non-Muscle Invasive Bladder Cancer (NMBC) through cutting-edge non-white light imaging techniques. Asieris Pharmaceuticals will not only spearhead the research efforts in this area but will also take charge of the worldwide commercialization of the sterile single-use fluorescent Cystoscope. Read the Full Press Release Here

UroViu Corp has introduced the brand-new Uro-GHD, a sterile, disposable cystoscope that seamlessly integrates with UroViu’s innovative Always Ready endoscopy system. Notably, the Uro-GHD boasts a cutting-edge 1280×720 pixel sensor, marking a groundbreaking advancement in the realm of portable, disposable endoscopy tools. Furthermore, this novel cystoscope incorporates an enhanced, pliable cannula with a tapered tip, prioritizing patient comfort. According to Dr. Joseph Liao from Stanford University School of Medicine, the substantial enhancement in image quality achieved with the UroViu GHD positions it at the forefront of digital cystoscope technology for bladder cancer surveillance. A recent survey of users underscores the newfound maneuverability coupled with superior optics and an updated HD sensor, enabling healthcare professionals to effortlessly and effectively carry out procedures such as bladder cancer surveillance and stent removals. UroViu’s Always Ready endoscopy system comprises a reusable, self-contained, highly portable handle and a suite of four purpose-designed, single-use cystoscopes. Read

UroViu Corp, a firm specializing in the creation and distribution of exceptionally portable single-use endoscopy solutions, has proudly announced its inclusion in the US Defense Logistics Agency’s Medical Equipment ECAT. Through a secured contract facilitated by Fidelis Sustainability Distribution, veterans will now gain access to cutting-edge cystoscopy equipment. As per the terms of the agreement, UroViu will offer its entire range of products at a predetermined price, exclusively for distribution by Fidelis. These products will be made accessible to over 1,200 VA and DOD healthcare facilities across the United States, collectively serving a remarkable 9 million enrolled veterans annually. Read the Full Press Release